This is an important limitation of these studies because it does not answer the question: can the expression of cTns in skeletal muscles lead to an increase in the serum levels of cTns in patients with CRF or hereditary skeletal myopathies? The gene discussed is CTNS; the disease is skeletal muscle disorder.